Read this article in:
Nantes-based GenSensor, a deeptech company that optimises the development and production of biomedicines, announced that it has secured €2M in a fresh round of funding.
GenSensor seeks to advance the research, manufacture, and use of novel medicines by reindustrialising their production in France and, more widely, by becoming a vital partner for innovators in the pharmaceutical industry.
Investors in this round
The funding came from GO Capital, Sodero Gestion and Bpifrance.
GO Capital is an independent management company that claims to be a major player in seed capital and venture capital in the region. The firm has nearly €350M AUM and mainly finances technology leaders in the digital, health and industry of the future sectors.